Versant Vantage I, L.p.
Affiliations
- at Lava Therapeutics Nv (LVTX), 2025-02-07
- at Monte Rosa Therapeutics Inc. (GLUE), 2024-10-30
- at Black Diamond Therapeutics Inc. (BDTX), 2024-08-30
- Large Shareholder at Contineum Therapeutics Inc. (CTNM), 2024-04-11
- Large Shareholder at Rayzebio Inc. (RYZB), 2023-09-15
- Large Shareholder at Oyster Point Pharma Inc. (OYST), 2023-01-04
- Large Shareholder at Repare Therapeutics Inc. (RPTX), 2022-06-07
- Large Shareholder at Aligos Therapeutics Inc. (ALGS), 2020-10-20
- Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-21
- Large Shareholder at Aprea Therapeutics Inc. (APRE), 2020-05-21
- Large Shareholder at Passage Bio Inc. (PASG), 2020-03-04
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| RPTX | $20.00 | 100,000 | $2,000,000.00 | 3,419,451 | 2020-06-23 | Filing |
| RPTX | $20.00 | 150,000 | $3,000,000.00 | 608,282 | 2020-06-23 | Filing |
| APRE | $15.00 | 333,333 | $4,999,995.00 | 333,333 | 2019-10-07 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| RPTX | $12.25 | 33,395 | $409,145.52 | 111,484 | 2022-06-03 | Filing |
| RPTX | $12.25 | 14,611 | $179,009.59 | 48,776 | 2022-06-03 | Filing |
| RPTX | $12.25 | 13,199 | $161,710.19 | 44,065 | 2022-06-03 | Filing |
| RPTX | $12.25 | 438,795 | $5,375,984.70 | 1,464,875 | 2022-06-03 | Filing |
| RPTX | $12.25 | 250,000 | $3,062,925.00 | 2,344,451 | 2022-06-03 | Filing |